![](https://nthumb.tpgimages.com/mid2_com_img/1339/17330/TOP16412949.jpg)
Bortezomib. Molecular model of the proteasome inhibitor drug bortezomib (chemical formula C19.H25.B.N4.O4), used to treat cancers. This was the first therapeutic proteasome inhibitor to be tested in humans. It has been used in the treatment of multiple myeloma and mantle cell lymphoma. Atoms are represented as spheres and are colour-coded: carbon (light blue), hydrogen (white), nitrogen (dark blue), oxygen (red) and boron (yellow).
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP16412949
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
1anti-cancerartworkbiochemicalbiochemistrybiologicalbiologyblackbackgroundbortecadbortezomibcancercancertreatmentchemicalchemistrychemotherapycutoutcutoutscut-outcut-outscutoutcutoutsdigitallygenerateddruggraphichealthcareillustrationinhibitorlymphomamedicalmedicationmedicinemodelmolecularmoleculemyelomaneomibnooneno-onenobodyoncologypharmaceuticalpharmaceuticspharmacologicalpharmacologyplainbackgroundproteaseproteasomeinhibitorproteinaseresearchspace-fillspace-filledspacefillspacefilledstructuretherapeutictreatmentvelcade
1anti-cancerartworkbackgroundbackgroundbiochemicalbiochemistrybiologicalbiologyblackbortecadbortezomibcancercancerchemicalchemistrychemotherapycutcutcut-outcut-outscutoutcutoutsdigitallydruggeneratedgraphichealthcareillustrationinhibitorinhibitorlymphomamedicalmedicationmedicinemodelmolecularmoleculemyelomaneomibnono-onenobodyoncologyoneoutoutspharmaceuticalpharmaceuticspharmacologicalpharmacologyplainproteaseproteasomeproteinaseresearchspace-fillspace-filledspacefillspacefilledstructuretherapeutictreatmenttreatmentvelcade